Search clinical trials for: Iron Isomaltoside

Total 1376 results

Intuitive Surgical

Recruiting

Real World Registry for Use of the Ion Endoluminal System

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Neoplasms by Site | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Multiple Pulmonary Nodules | Lung Cancer

United States
Heidelberg University

Recruiting

Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base (HIT-1)

Chordoma | Tumor | Treatment

Germany
University Hospital Heidelberg

Active, not recruiting

Carbon Ion Radiotherapy for Atypical Meningiomas (MARCIE)

Meningioma

Germany
University Hospital Heidelberg

Completed

Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent Rectal Cancer (PANDORA)

Recurrent Rectal Cancer

Germany
University Hospital Heidelberg

Withdrawn

Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial (PHOENIX-01)

Locally Advanced Pancreatic Cancer

Germany
University of Texas Southwestern Medical Center
AMAG Pharmaceuticals, Inc.

Terminated

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery (APART)

Cardiovascular Disease | Anemia

United States
Reckitt Benckiser LLC

Completed

Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet

Healthy Subjects
MegaPro Biomedical Co. Ltd.

Completed

Phase I , MTD, Pharmacokinetic, Safety/Tolerability, Efficacy of IOP Injection for MRI in Healthy Subjects

Magnetic Resonance Imaging

Taiwan
Denver Health and Hospital Authority
National Trauma Research Institute

Completed

IV Iron for the Anemia of Traumatic Critical Illness (IATCI)

Trauma | ICU Anemia

United States
Novartis Pharmaceuticals

Completed

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Myelodysplastic Syndromes | Fanconi Syndrome | Anemia, Aplastic | Beta-thalassemia | Anemia, Diamond-Blackfan

United States
Novartis Pharmaceuticals

Withdrawn

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
AMAG Pharmaceuticals, Inc.

Completed

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Anemia

United States
Shanghai Proton and Heavy Ion Center

Recruiting

Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery

Pancreatic Carcinoma

China
Shanghai Proton and Heavy Ion Center

Recruiting

Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

Pancreatic Cancer Non-resectable

China
Shanghai Proton and Heavy Ion Center

Recruiting

12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer

Prostate Cancer | Radiotherapy

China
Shanghai Proton and Heavy Ion Center

Recruiting

Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer

Prostate Carcinoma

China
Intuitive Surgical

Completed

A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions

Lung Cancer | Pulmonary Nodule

United States
Ionis Pharmaceuticals, Inc.

Terminated

A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)

Chronic Obstructive Pulmonary Disease | Chronic Bronchitis

Germany, Czechia, Hungary, United Kingdom
Novartis Pharmaceuticals

Completed

Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis (MIMAS)

Iron Overload

United Kingdom, Italy, Oman, United Arab Emirates, Lebanon, Thailand, Egypt
Kermanshah University of Medical Sciences

Unknown

Application of Desferal to Treat COVID-19

COVID-19

Iran, Islamic Republic of
Novartis Pharmaceuticals

Completed

Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation

Chronic Iron Overload

Austria, Italy, Greece
Novartis Pharmaceuticals

Withdrawn

Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia (CENTAurus)

Thalassemia (Transfusion Delendent)
HaEmek Medical Center, Israel

Completed

Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox

Iron Overload | Thalassemia

Israel
Novartis Pharmaceuticals

Completed

Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

Transfusional Iron Overload

Italy
Wolfson Medical Center
Hadassah Medical Organization; Tel-Aviv Sourasky Medical Center; Sheba Medical... and other collaborators

Completed

Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load

Myelodysplastic Syndrome

Israel
Swiss Federal Institute of Technology
University Hospital, Zürich; ETH Zurich

Completed

Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
Watson Pharmaceuticals

Completed

Effect of Two Iron Preparations on Protein in the Urine

Anemia, Iron-Deficiency | Kidney Failure, Chronic

United States
Cedars-Sinai Medical Center

Recruiting

Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes (OC)

Ligament Injury

United States
Sunnybrook Health Sciences Centre
Unity Health Toronto

Completed

Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia (DEODO)

Anemia | Iron Deficiency Anemia

Canada
China-Japan Friendship Hospital

Not yet recruiting

Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia

Heart Failure | Chronic Kidney Diseases | Anemia
Vifor (International) Inc.
Tigermed Consulting Co., Ltd

Completed

To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia

Iron Deficiency Anemia

China
Novartis Pharmaceuticals

Completed

Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.

Hepatic Impairment

Germany
GlaxoSmithKline

Completed

Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents

Anaemia

Japan
Novartis Pharmaceuticals

Terminated

Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study (MACS1574)

Myelodysplastic Syndrome | Transfusional Iron Overload

Spain, France, Italy, South Africa
Novartis

Completed

A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

Beta-Thalassemia | Hemosiderosis

Egypt, Lebanon, Oman, Saudi Arabia, Syrian Arab Republic
Novartis Pharmaceuticals

Completed

This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.

Myelodysplastic Syndrome | Thalassemia

Russian Federation
The First Affiliated Hospital, Guangzhou University...

Unknown

Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome

Postpartum Anemia

China
Ain Shams University

Unknown

An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients

Beta Thalassemia Major

Egypt
National Research Council, Spain
Ministry of Science and Innovation, Spain; Grupo Leche Pascual; Madrid Salud,...

Completed

Iron Fortified Beverages and Application in Women Predisposed to Anemia (FeDrink)

Iron-deficiency Anemia
CES University
Nutreva S.A.S.; Foundation Child Care - FAN

Completed

Ferrous Sulfate Versus Iron Amino Acid Chelate

Iron Deficiency

Colombia
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study

Liver Iron Overload

Italy
Samsung Medical Center
AstraZeneca

Completed

BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer

To Investigate the Prevalence of BRCA 1/2 Mutation Among Ovarian Cancer
Dita Aditianingsih

Completed

Comparison of Transthoracic Electrical Bioimpedance and Pulse Contour Analysis in Renal Transplantation Patients

Hemodynamic Monitoring

Indonesia
Stanford University
Harvard Pilgrim Health Care

Completed

Comparing Designs for Restaurant "Eco-Labels"

Food Preferences

United States
B. Braun Melsungen AG

Completed

Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)

Covid19

Germany
B. Braun Melsungen AG
CeGaT GmbH

Completed

Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Germany
Shanghai Proton and Heavy Ion Center

Unknown

Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center

Unknown

Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center

Terminated

Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
The First Affiliated Hospital with Nanjing Medical...
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus

Heart Aneurysm

China

Search clinical trials for: Iron Isomaltoside

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations